Pulmatrix, Inc. SEC filings PULM
Pulmatrix, Inc. has 652 filings in SEC EDGAR's recent list, going back to May 24, 2013. Its latest annual report, Form ARS, was filed on Oct 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 425 | Filing | Oct 30, 2026 | — |
| EFFECT | Filing | Oct 22, 2026 | — |
| 425 | Filing | Oct 22, 2026 | — |
| 425 | Filing | Oct 13, 2026 | — |
| EFFECT | Filing | Sep 25, 2026 | — |
| 425 | Filing | Sep 22, 2026 | — |
| 425 | Filing | Jun 5, 2026 | — |
| DRS | Filing | May 14, 2026 | — |
| D | Filing | Apr 15, 2026 | — |
| 425 | Filing | Mar 26, 2026 | — |
| 425 | Filing | Jun 16, 2025 | — |
| EFFECT | Filing | May 9, 2025 | — |
| CORRESP | Letter to the SEC | May 8, 2025 | — |
| CORRESP | Letter to the SEC | May 7, 2025 | — |
| CORRESP | Letter to the SEC | Apr 17, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 17, 2025 | — |
| 425 | Filing | Jan 22, 2025 | — |
| EFFECT | Filing | May 30, 2024 | — |
| CORRESP | Letter to the SEC | May 28, 2024 | — |
| UPLOAD | Letter from the SEC | May 23, 2024 | — |
| D | Filing | Jul 20, 2021 | — |
| EFFECT | Filing | Jun 9, 2021 | — |
| CORRESP | Letter to the SEC | Jun 7, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2021 | — |
| D | Filing | Feb 23, 2021 | — |
| EFFECT | Filing | Aug 13, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 11, 2020 | — |
| CORRESP | Letter to the SEC | Aug 11, 2020 | — |
| D | Filing | Jul 20, 2020 | — |
| EFFECT | Filing | Jul 2, 2020 | — |
| CORRESP | Letter to the SEC | Jul 1, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 1, 2020 | — |
| D | Filing | Apr 24, 2020 | — |
| EFFECT | Filing | Apr 10, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 8, 2019 | — |
| CORRESP | Letter to the SEC | Apr 8, 2019 | — |
| EFFECT | Filing | Apr 3, 2019 | — |
| CORRESP | Letter to the SEC | Apr 2, 2019 | — |
| CORRESP | Letter to the SEC | Apr 2, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 25, 2019 | — |
| EFFECT | Filing | Mar 15, 2019 | — |
| CORRESP | Letter to the SEC | Mar 14, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 14, 2019 | — |
| D | Filing | Feb 14, 2019 | — |
| D | Filing | Feb 14, 2019 | — |
| D | Filing | Feb 14, 2019 | — |
| RW | Filing | Feb 6, 2019 | — |
| D | Filing | Dec 18, 2018 | — |
| EFFECT | Filing | Mar 28, 2018 | — |
| CORRESP | Letter to the SEC | Mar 28, 2018 | — |
| CORRESP | Letter to the SEC | Mar 28, 2018 | — |
| CORRESP | Letter to the SEC | Mar 27, 2018 | — |
| CORRESP | Letter to the SEC | Mar 26, 2018 | — |
| CORRESP | Letter to the SEC | Mar 26, 2018 | — |
| UPLOAD | Letter from the SEC | Mar 19, 2018 | — |
| CT ORDER | Filing | Dec 12, 2017 | — |
| CT ORDER | Filing | Sep 19, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 21, 2016 | — |
| CORRESP | Letter to the SEC | Oct 11, 2016 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2016 | — |
| EFFECT | Filing | Aug 3, 2016 | — |
| CORRESP | Letter to the SEC | Aug 1, 2016 | — |
| CORRESP | Letter to the SEC | Jul 29, 2016 | — |
| UPLOAD | Letter from the SEC | Jul 25, 2016 | — |
| EFFECT | Filing | Sep 30, 2015 | — |
| D | Filing | Jun 30, 2015 | — |
| D | Filing | Jun 30, 2015 | — |
| D | Filing | Jun 30, 2015 | — |
| D | Filing | Jun 30, 2015 | — |
| D | Filing | Jun 16, 2015 | — |
| 425 | Form 8-k | Jun 12, 2015 | — |
| EFFECT | Filing | May 4, 2015 | — |
| 425 | Form 425 | Apr 8, 2015 | — |
| EFFECT | Filing | Aug 12, 2014 | — |
| POS EX | Filing | Mar 25, 2014 | — |
| CT ORDER | Filing | Mar 24, 2014 | — |
| EFFECT | Filing | Mar 21, 2014 | — |
| CORRESP | Letter to the SEC | Mar 20, 2014 | — |
| CORRESP | Letter to the SEC | Mar 14, 2014 | — |
| CORRESP | Letter to the SEC | Mar 10, 2014 | — |
| UPLOAD | Letter from the SEC | Mar 6, 2014 | — |
| CERTNAS | Auto-generated paper document | Nov 19, 2013 | — |
| CORRESP | Letter to the SEC | Nov 18, 2013 | — |
| CORRESP | Letter to the SEC | Nov 18, 2013 | — |
| 8-A12B | Filing | Nov 13, 2013 | — |
| CORRESP | Letter to the SEC | Oct 15, 2013 | — |
| UPLOAD | Letter from the SEC | Aug 23, 2013 | — |
| CORRESP | Letter to the SEC | Aug 8, 2013 | — |
| UPLOAD | Letter from the SEC | Jun 24, 2013 | — |
| DRS | Filing | May 24, 2013 | — |
Showing 90 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PULM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Framingham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1574235
- Former names
- Ruthigen, Inc. (until Jun 16, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.